GSK Investigational Site
Seoul, 135-710, South Korea
NCT Number: NCT01390935
The purpose of this study is to survey the guideline compliance of the cardiologists in the treatment of systolic heart failure in Korea
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seoul, 135-710, South Korea
Major improvement in the medical management of CHF has been achieved in the past decades.
But there is no doubt that prognosis of heart failure patients remains poor. The compliance to the standard treatment can be one of reasons. But very little data concerning this in Korea is available.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
guideline adherence of physician
Other names: ACEI, ARB, BB, aldosterone antagonist
Time frame: 1year
Modified percentage based on each participant's condition
Time frame: 1year
ARB, BB, ACE-I, aldosterone antagonist
Time frame: 1year
ARB, BB, ACE-I, aldosterone antagonist
Time frame: 1year
All cause mortality in 1-year after treatment of systolic heart failure
Time frame: 1year
All cause hospitalization in 1-year after treatment of systolic heart failure
Time frame: 1year
GlaxoSmithKline
Industry
SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real WorldMulticenter, Retrospective Observation Study in Korea
Acronym: SUGAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00303979
Cardiovascular Diseases, Heart Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT01074307
Cardiovascular Diseases, Heart Diseases
Seoul, South Korea
View Trial DetailsNCT05677100
ADHF, Cardio-Renal Syndrome
Phoenix, Arizona, United States
View Trial DetailsNCT02729922
Cardiovascular Diseases, Heart Diseases
Philadelphia, Pennsylvania, United States
View Trial Details